Total body computed tomography scan in the initial work‐up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O‐CLL1‐GISL study

Total body computed tomography (TB‐CT) scan is not mandatory in the diagnostic/staging algorithm of chronic lymphocytic leukemia (CLL). The aim of this study was to determine the value and prognostic significance of TB‐CT scan in early stage CLL patients. Baseline TB‐CT scan was performed in 240 Binet stage A CLL patients (179 Rai low‐ and 61 Rai intermediate‐risk) included in a prospective multicenter observational study (clinicaltrial.gov ID:NCT00917549). The cohort included 69 clinical monoclonal B lymphocytosis (cMBLs). Patients were restaged considering only radiological data. Following TB‐CT scans, 20% of cases reclassified as radiologic Binet (r‐Binet) stage B. r‐Binet B patients showed a higher incidence of unfavorable cytogenetic abnormalities (P = 0.027), as well as a shorter PFS (P = 0.001). At multivariate analysis, r‐Binet stage [HR = 2.48; P = 0.004] and IGHV mutational status [HR = 3.01; P = 0.002] retained an independent predictive value for PFS. Among 179 Rai low‐risk cases, 100 were redefined as r‐Rai intermediate‐risk based upon TB‐CT scan data, showing a higher rate of cases with higher ZAP‐70 (P = 0.033) and CD38 expression (P = 0.029) and β2‐microglobulin levels (P < 0.0001), as well as a shorter PFS than those with r‐Rai low‐risk (P = 0.008). r‐Rai stage [HR = 2.78; P = 0.046] and IGHV mutational status [HR = 4.25; P = 0.009] retained a significant predictive value for PFS at multivariate analysis. Forty‐two percent of cMBL patients were reclassified as r‐small lymphocytic lymphomas (r‐SLLs) by TB‐CT scan. TB‐CT scan appears to provide relevant information in early stage CLL related to the potential and the timing of patients to progress towards the more advanced disease stages. Am. J. Hematol. 88:539–544, 2013. © 2013 Wiley Periodicals, Inc.

[1]  B. Sarina,et al.  Impact of B-cell count and imaging screening in cMBL: any need to revise the current guidelines? , 2012, Leukemia.

[2]  S. Molica,et al.  The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia. , 2011, Blood.

[3]  S. Molica,et al.  Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia , 2009, British journal of haematology.

[4]  D. Rossi,et al.  The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors , 2009, British journal of haematology.

[5]  Massimo Gentile,et al.  Predictive value of β2-microglobulin (β2-m) levels in chronic lymphocytic leukemia since Binet A stages , 2009, Haematologica.

[6]  K. Nilsson,et al.  Beta 2-microglobulin in chronic lymphocytic leukaemia. , 2009, Scandinavian journal of haematology.

[7]  Michael Hallek,et al.  Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. , 2008, Blood.

[8]  N. Chiorazzi,et al.  Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells , 2008, Haematologica.

[9]  E. Giné,et al.  Abdominal computed tomography predicts progression in patients with Rai stage 0 chronic lymphocytic leukemia. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  H. Kantarjian,et al.  Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  J. Armitage,et al.  Staging Non‐Hodgkin Lymphoma , 2005, CA: a cancer journal for clinicians.

[12]  T. Stankovic,et al.  Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL. , 2005, Blood.

[13]  M. Blaufox,et al.  A metaanalysis of 18F‐2‐deoxy‐2‐fluoro‐D‐glucose positron emission tomography in the staging and restaging of patients with lymphoma , 2005, Cancer.

[14]  K. Jain,et al.  Normal organ volume assessment from abdominal CT , 2004, Abdominal Imaging.

[15]  R. Reznek,et al.  Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  B. Cheson,et al.  Pre- and post-treatment evaluation of non-Hodgkin's lymphoma. , 2002, Best practice & research. Clinical haematology.

[17]  H. Minn,et al.  Nodal staging of lymphoma with whole-body PET: comparison of. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  J. Whittaker,et al.  Deletions at 11q identify a subset of patients with typical CLL who show consistent disease progression and reduced survival , 1997, Leukemia.

[19]  M. James,et al.  11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. , 1997, Blood.

[20]  M. Grever,et al.  National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. , 1996, Blood.

[21]  A. Polliack,et al.  Pulmonary involvement as the major manifestation of chronic lymphocytic leukemia. , 1992, Leukemia & lymphoma.

[22]  B. Gross,et al.  Upper abdominal lymph nodes: criteria for normal size determined with CT. , 1991, Radiology.

[23]  M Tubiana,et al.  Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Mark J. Thomas,et al.  A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis , 1981, Cancer.

[25]  S. Malek,et al.  Chronic Lymphocytic Leukemia , 2019, Methods in Molecular Biology.

[26]  D C Case,et al.  Clinical staging of chronic lymphocytic leukemia. , 1977, The Journal of the Maine Medical Association.